[Drugs of microbial origin for treatment of atherosclerosis].
Bibikova
M V
MV
National Research Centre of Antibiotics, Moscow.
Bondareva
N S
NS
D000818:Animals; D000924:Anticholesteremic Agents / Q000302:isolation & purification / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy*; D002784:Cholesterol / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000302:isolation & purification / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000302:isolation & purification / Q000627:therapeutic use*; D003904:Mitosporic Fungi / Q000378:metabolism*; D013185:Squalene / Q000037:antagonists & inhibitors
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D013185:Squalene; D002784:Cholesterol
Preparaty mikrobnogo proiskhozhdeniia dlia lecheniia ateroskleroza.